These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Oral immunization with a novel lipid-based adjuvant protects against genital Chlamydia infection. Hickey DK, Aldwell FE, Beagley KW. Vaccine; 2010 Feb 17; 28(7):1668-72. PubMed ID: 20026449 [Abstract] [Full Text] [Related]
26. Comparison of the nine polymorphic membrane proteins of Chlamydia trachomatis for their ability to induce protective immune responses in mice against a C. muridarum challenge. Pal S, Favaroni A, Tifrea DF, Hanisch PT, Luczak SET, Hegemann JH, de la Maza LM. Vaccine; 2017 May 02; 35(19):2543-2549. PubMed ID: 28385608 [Abstract] [Full Text] [Related]
28. Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein. Sun G, Pal S, Weiland J, Peterson EM, de la Maza LM. Vaccine; 2009 Aug 06; 27(36):5020-5. PubMed ID: 19446590 [Abstract] [Full Text] [Related]
29. Induction of protective immunity against a Chlamydia trachomatis genital infection in three genetically distinct strains of mice. Pal S, Peterson EM, de la Maza LM. Immunology; 2003 Nov 06; 110(3):368-75. PubMed ID: 14632665 [Abstract] [Full Text] [Related]
31. Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge. Pal S, Theodor I, Peterson EM, de la Maza LM. Infect Immun; 1997 Aug 06; 65(8):3361-9. PubMed ID: 9234798 [Abstract] [Full Text] [Related]
32. GM-CSF transgene-based adjuvant allows the establishment of protective mucosal immunity following vaccination with inactivated Chlamydia trachomatis. Lu H, Xing Z, Brunham RC. J Immunol; 2002 Dec 01; 169(11):6324-31. PubMed ID: 12444139 [Abstract] [Full Text] [Related]
33. Viral-vectored boosting of OmcB- or CPAF-specific T-cell responses fail to enhance protection from Chlamydia muridarum in infection-immune mice and elicits a non-protective CD8-dominant response in naïve mice. Poston TB, Girardi J, Polson AG, Bhardwaj A, Yount KS, Jaras Salas I, Trim LK, Li Y, O'Connell CM, Leahy D, Harris JM, Beagley KW, Goonetilleke N, Darville T. Mucosal Immunol; 2024 Oct 01; 17(5):1005-1018. PubMed ID: 38969067 [Abstract] [Full Text] [Related]
34. A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge. Pal S, Tatarenkova OV, de la Maza LM. Immunology; 2015 Nov 01; 146(3):432-43. PubMed ID: 26423798 [Abstract] [Full Text] [Related]
36. Induction of protection in mice against a respiratory challenge by a vaccine formulated with the Chlamydia major outer membrane protein adjuvanted with IC31®. Cheng C, Cruz-Fisher MI, Tifrea D, Pal S, Wizel B, de la Maza LM. Vaccine; 2011 Mar 16; 29(13):2437-43. PubMed ID: 21276442 [Abstract] [Full Text] [Related]
37. Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria. Pal S, Peterson EM, de la Maza LM. Infect Immun; 2005 Dec 16; 73(12):8153-60. PubMed ID: 16299310 [Abstract] [Full Text] [Related]